As part of its Working Group 4 Digital-Motor Biomarkers, the Ataxia Global Initiative (AGI) has developed a new webinar series exploring the potential of digital assessments for use in ataxia clinical trials. The series will cover emerging digital tools and approaches for measuring disease progression and capturing clinically meaningful changes, while addressing key challenges in validation, regulatory acceptance, and the development of digital outcome measures to support trial readiness in ataxias.
Registration:register at Eveeno
Program
From Digital Assessment to Clinical Trial: Regulatory Considerations and Implications for Ataxia
Speaker: tba
2 December 2026
At-home Wearables and Machine Learning as Digital Outcome Measure for Ataxia Clinical Trials
Anoopum Gupta (Boston, USA)
9 December 2026, 3-4 pm CET
Establishing and Validating a Patient-Meaningful Digital Gait Endpoint for Disease Progression
Winfried Ilg (Tübingen, Germany)
13 January 2027, 3-4 pm CET
Composite Digital Balance Score as Outcome Measure for Ataxia Clinical Trials
James McNames (Portland, US)
Vrutang Shah (Portland, US)
27 January, 5-6 pm CET
Sensor Free Motion Capture: Possible Application in Clinical Trials
Philipp Wegner (Bonn, Germany)
Jennifer Faber (Bonn, Germany)
17 March 2027, 3-4 pm CET
Challenges and Future Directions of Eye Movement Recordings in Hereditary Ataxias
Alex Tarnutzer (Zurich, Switzerland)
7 April 2027, 3-4 pm CEST
Quantitative Speech Assessment in Ataxia and Other Neurodegenerative Diseases
Adam Vogel (Melbourne, Australia)
21 April 2027, 1-2 pm CEST
Towards Smartphone-Based Remote Assessments in Ataxia
Lukas Beichert (Tübingen, Germany)
12 Mai 2027, 3-4 pm CEST
Instrumented Motor Assessments in Ataxia: Developing Digital Measures for Natural History and Clinical Trials
Gessica Vasco (Rome, Italy)
9 June 2027, 3-4 pm CEST
Digital Assessment in HD
tbc
Final Webinar: Industry Session
7 July 2027, 5-6 pm CEST